On May 15th, according to the media report of "Tech News", the latest financial report released by Take Two Interactive Software Company in the fiscal year 2025 disclosed its revenue and business development status.
more
In the tide of globalization, every move made by enterprises can trigger strong repercussions due to legal and cultural differences among countries.
more
Recently, US President Trump announced on social media that on May 12 local time, he signed an executive order at the White House, stipulating that the United States will purchase medicines at the world's lowest prices.
more
Since Donald Trump became the President of the United States, a series of tariff policies imposed on China have further intensified trade frictions between the two nations.
more
Originally, US business travel, which was highly expected, showed signs of optimism in early 2025.
more
Recently, American retail giants such as Walmart have announced price increase plans, which have drawn widespread attention from the market.
more
On May 16th, according to the media report of "Science and Technology News", NVIDIA recently increased its stake in cloud computing service provider CoreWeave to 7%.
more
Recently, China and United States released a "Joint Statement on Economic and Trade Talks" in Geneva, Switzerland, announcing the suspension of some tariff hikes and the establishment of a normalized consultation mechanism.
more
According to preliminary statistics released by the Reserve Bank of India on May 12th, the net outflow of India's capital account in the 2024 fiscal year reached an unprecedented $98.5 billion, equivalent to 2.8% of the country's GDP.
more
In the Golden Palace in Riyadh, the handshake between US President Donald Trump and Saudi Crown Prince Mohammed bin Salman once again set off a global public opinion storm.
more
July 8, 2025 – CStone Pharmaceuticals (Stock Code: 2616.HK), an innovative biopharmaceutical company focused on anti-tumor drug research and development, announced that it has reached an exclusive strategic cooperation with Istituto Gentili ("Gentili"), a century-old oncology biopharmaceutical company with deep roots in the European market, regarding the commercialization of sugemalimab in Western Europe and the UK.
© Copyright 2025, All Rights Reserved
